BioSyent Statistics

Total Valuation

BioSyent has a market cap or net worth of CAD 133.48 million. The enterprise value is 117.50 million.

Market Cap	133.48M
Enterprise Value	117.50M

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Nov 29, 2024

Share Statistics

BioSyent has 11.37 million shares outstanding. The number of shares has decreased by -3.05% in one year.

Current Share Class	n/a
Shares Outstanding	11.37M
Shares Change (YoY)	-3.05%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	13.33%
Owned by Institutions (%)	19.25%
Float	8.77M

Valuation Ratios

The trailing PE ratio is 19.62 and the forward PE ratio is 15.50.

PE Ratio	19.62
Forward PE	15.50
PS Ratio	3.97
PB Ratio	3.64
P/TBV Ratio	4.19
P/FCF Ratio	20.05
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.66, with an EV/FCF ratio of 17.65.

EV / Earnings	16.53
EV / Sales	3.41
EV / EBITDA	13.66
EV / EBIT	14.20
EV / FCF	17.65

Financial Position

The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.03.

Current Ratio	3.92
Quick Ratio	3.04
Debt / Equity	0.03
Debt / EBITDA	0.13
Debt / FCF	0.16
Interest Coverage	134.43

Financial Efficiency

Return on equity (ROE) is 19.77% and return on invested capital (ROIC) is 13.94%.

Return on Equity (ROE)	19.77%
Return on Assets (ROA)	11.91%
Return on Capital (ROIC)	13.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.79
Inventory Turnover	1.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.91% in the last 52 weeks. The beta is 0.93, so BioSyent's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	+31.91%
50-Day Moving Average	11.29
200-Day Moving Average	10.04
Relative Strength Index (RSI)	57.06
Average Volume (20 Days)	2,696

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioSyent had revenue of CAD 34.51 million and earned 7.11 million in profits. Earnings per share was 0.60.

Revenue	34.51M
Gross Profit	27.41M
Operating Income	8.28M
Pretax Income	9.39M
Net Income	7.11M
EBITDA	8.47M
EBIT	8.28M
Earnings Per Share (EPS)	0.60

Full Income Statement

Balance Sheet

The company has 17.06 million in cash and 1.08 million in debt, giving a net cash position of 15.98 million or 1.41 per share.

Cash & Cash Equivalents	17.06M
Total Debt	1.08M
Net Cash	15.98M
Net Cash Per Share	1.41
Equity (Book Value)	37.35M
Book Value Per Share	3.22
Working Capital	20.52M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.72 million and capital expenditures -63,501, giving a free cash flow of 6.66 million.

Operating Cash Flow	6.72M
Capital Expenditures	-63,501
Free Cash Flow	6.66M
FCF Per Share	0.59

Full Cash Flow Statement

Margins

Gross margin is 79.42%, with operating and profit margins of 23.99% and 20.60%.

Gross Margin	79.42%
Operating Margin	23.99%
Pretax Margin	27.20%
Profit Margin	20.60%
EBITDA Margin	24.55%
EBIT Margin	23.99%
FCF Margin	19.29%

Dividends & Yields

This stock pays an annual dividend of 0.18, which amounts to a dividend yield of 1.53%.

Dividend Per Share	0.18
Dividend Yield	1.53%
Dividend Growth (YoY)	12.50%
Years of Dividend Growth	2
Payout Ratio	28.69%
Buyback Yield	3.05%
Shareholder Yield	4.58%
Earnings Yield	5.10%
FCF Yield	4.99%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioSyent has an Altman Z-Score of 10.67.

Altman Z-Score	10.67
Piotroski F-Score	n/a